OVID THERAPEUTICS DL-,001 financial statements, including revenue, expenses, profit, and loss
The total revenue of 1OT for the last quarter is 137.16 k EUR, and it's 6.95% higher compared to the previous quarter. The net income of Q1 24 is -10.84 M EUR.